Condition: Hydrocephalus · Sponsor: Milton S. Hershey Medical Center
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity. This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.
This description comes directly from the study's public registry record.
Sara Craig, MNR, BS · 717-531-0003 · scraig2@pennstatehealth.psu.edu
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Decision made to perform the procedure by the primary consultant * Age 18 or older * Neuro ICU stay * Newly diagnosed hydrocephalus * Has a recent CT within the past 24 hrs * Normal platelets and coagulation profile * No active infection or currently on antibiotics * The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging Exclusion Criteria: * Age \<18 * Not in Neuro ICU setting * Previous placement of a ventricular catheter * More than 50 percent of the fluid compartment is filled with blood by CT scan * Time to include in the trial prohibited by clinical personnel
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Penn State Health Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.